What is Pulse Biosciences, Inc.'s operating lease liabilities?

Pulse Biosciences, Inc. (PLSE) reported operating lease liabilities of -$375K in Q1 2026.

How has Pulse Biosciences, Inc.'s operating lease liabilities changed year-over-year?

Pulse Biosciences, Inc.'s operating lease liabilities decreased by 16.8% year-over-year, from -$321K to -$375K.

What is the long-term trend for Pulse Biosciences, Inc.'s operating lease liabilities?

Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s operating lease liabilities has grown at a 26.0% compound annual growth rate (CAGR), from -$542K to -$1.37M.

Pulse Biosciences, Inc. PLSE Operating lease liabilities

Operating lease liabilities at other companies

Merit Medical SystemsMMSI

——

Ocular TherapeutixOCUL

——

PVL

Palvella TherapeuticsPVLA

——

Other financials

Income statement

See full

Revenue$401.0K—

Gross profit$31.0K—

Operating income-$19.2M-6.1%

Net income-$18.6M-10.6%

EPS (diluted)-$0.49-2.1%

Balance sheet

See full

Cash & equivalents$68.3M-42.7%

Total debt$7.2M-16.6%

Total equity$66.3M-44.0%

Total assets$81.6M-38.8%

Cash flow

See full

Operating cash flow-$14.6M-7.9%

CapEx$33.0K-26.7%

Free cash flow-$14.6M-7.8%

Valuation

See full

Market cap$1.77B+38.4%

Profitability

See full

Gross margin-4,067.5%—

Operating margin-10,392.1%—

Net margin-9,929%—

FCF margin-7,390%—

Returns & leverage

See full

Return on equity-80.7%+3.1pp

Debt / equity0.1×0.0×

Current ratio7.3×-8.3×

Where this comes from

Reported directly by Pulse Biosciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInOperatingLeaseLiability.

The official record: Pulse Biosciences, Inc.’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulse Biosciences, Inc.'s operating lease liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulse Biosciences, Inc.'s operating lease liabilities?: Pulse Biosciences, Inc. (PLSE) reported operating lease liabilities of -$375K in Q1 2026.
How has Pulse Biosciences, Inc.'s operating lease liabilities changed year-over-year?: Pulse Biosciences, Inc.'s operating lease liabilities decreased by 16.8% year-over-year, from -$321K to -$375K.
What is the long-term trend for Pulse Biosciences, Inc.'s operating lease liabilities?: Over 4 years (2021 to 2025), Pulse Biosciences, Inc.'s operating lease liabilities has grown at a 26.0% compound annual growth rate (CAGR), from -$542K to -$1.37M.